Ampio pharmaceuticals, inc. – product pipeline review – 2012


Published on

2012 | Ampio Pharmaceuticals, Inc. – Product Pipeline Review – 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Ampio pharmaceuticals, inc. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Ampio Pharmaceuticals, Inc. – Product Pipeline Review –2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Market Direct’s pharmaceuticals report, “Ampio Pharmaceuticals, Inc. -Product Pipeline Review - 2012” provides data on the Ampio Pharmaceuticals, Inc.’sresearch and development focus. The report includes information on currentdevelopmental pipeline, complete with latest updates, and features on discontinuedand dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Ampio Pharmaceuticals, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from AmpioPharmaceuticals, Inc. and industry-specific third party sources, put together byGlobal Markets Direct’s team.Scope
  2. 2. - Ampio Pharmaceuticals, Inc. - Brief Ampio Pharmaceuticals, Inc. overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Ampio Pharmaceuticals, Inc. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 4List of Figures 4Ampio Pharmaceuticals, Inc. Snapshot 5Ampio Pharmaceuticals, Inc. Overview 5Key Information 5Key Facts 5Arena Pharmaceuticals, Inc. – Research and Development Overview 6Key Therapeutic Areas 6Arena Pharmaceuticals, Inc. – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Arena Pharmaceuticals, Inc. – Pipeline Products Glance 10Arena Pharmaceuticals, Inc. – Late Stage Pipeline 10Phase III Products/Combination Treatment Modalities 10Arena Pharmaceuticals, Inc. Clinical Stage Pipeline Products 11Phase II Products/Combination Treatment Modalities 11Phase I Products/Combination Treatment Modalities 12Arena Pharmaceuticals, Inc. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13Arena Pharmaceuticals, Inc. – Drug Profiles 14Ampion 14Product Description 14Mechanism of Action 14R&D Progress 14DMI-4983 16Product Description 16
  3. 3. Mechanism of Action 16R&D Progress 16DMI-9523 17Product Description 17Mechanism of Action 17R&D Progress 17Optina 18Product Description 18List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1Alexion Pharmaceuticals, Inc. – Product Pipeline Review – 2012Alnylam Pharmaceuticals, Inc – Product Pipeline Review – 2012Ampio Pharmaceuticals, Inc. – Product Pipeline Review – 2012Arena Pharmaceuticals, Inc. – Product Pipeline Review – 2012ArQule, Inc. – Product Pipeline Review – 2012Baxter International Inc. – Product Pipeline Review – 2012
  4. 4. BioCryst Pharmaceuticals, Inc. – Product Pipeline Review – 2012Columbia Laboratories Inc. – Product Pipeline Review – 2012Corcept Therapeutics Incorporated – Product Pipeline Review – 2012Curis, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: